Insider Transactions in Q1 2021 at Exact Sciences Corp (EXAS)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 17
2021
|
Jacob A Orville EVP, GM, Screening |
SELL
Open market or private sale
|
Direct |
1,033
-22.83%
|
$146,686
$142.66 P/Share
|
|
Feb 16
2021
|
Sarah Condella EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
2,030
+2.83%
|
-
|
|
Feb 16
2021
|
Kevin T Conroy President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
31,132
+3.71%
|
-
|
|
Feb 16
2021
|
D Scott Coward |
BUY
Exercise of conversion of derivative security
|
Direct |
3,972
+42.96%
|
-
|
|
Feb 16
2021
|
Jeffrey Thomas Elliott Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,972
+8.58%
|
-
|
|
Feb 16
2021
|
Graham Peter Lidgard Chief Science Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,972
+9.53%
|
-
|
|
Feb 16
2021
|
Jacob A Orville EVP, GM, Screening |
BUY
Exercise of conversion of derivative security
|
Direct |
2,030
+30.97%
|
-
|
|
Feb 05
2021
|
Kevin T Conroy President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,543
+2.21%
|
$87,715
$5.7 P/Share
|
|
Feb 01
2021
|
Kevin T Conroy President and CEO |
SELL
Open market or private sale
|
Direct |
30,344
-3.84%
|
$4,187,472
$138.07 P/Share
|
|
Jan 04
2021
|
Kevin T Conroy President and CEO |
SELL
Open market or private sale
|
Direct |
31,814
-3.71%
|
$4,072,192
$128.74 P/Share
|